+ Follow GOETTINGEN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 180239
[Title] => Clot-dissolving therapy stops submassive PE
[Summary] => INGELHEIM, Germany Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.
[DatePublished] => 2002-10-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
GOETTINGEN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 180239
[Title] => Clot-dissolving therapy stops submassive PE
[Summary] => INGELHEIM, Germany Clinical trial results published last week in the New England Journal of Medicine demonstrated that the clot-dissolving agent alteplase (Actilyse tPA) can prevent the clinical deterioration of patients with submassive pulmonary embolism.
[DatePublished] => 2002-10-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
October 17, 2002 - 12:00am